Finding new brain imaging tools to better understand diseases
Accelerating the discovery and development of neurotracers via high-throughput radiochemistry
This study is working on creating new imaging tools that can help doctors see what's happening in the brain more clearly, which could lead to better ways to diagnose and treat brain conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11045746 on NIH RePORTER |
What this research studies
This research focuses on developing new neurotracers that can be used in positron-emission tomography (PET) to visualize biological targets in the brain. By improving the speed and efficiency of the radiochemistry process, the researchers aim to create reliable imaging agents that can help in understanding disease progression and treatment responses. Patients may benefit from enhanced diagnostic capabilities and the development of novel therapeutics that target specific brain functions and disorders. The study involves optimizing the synthesis conditions for these tracers to ensure they can be produced reliably and cost-effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological disorders or those at risk for such conditions who may benefit from advanced imaging techniques.
Not a fit: Patients with conditions unrelated to neurological function or those who do not require imaging studies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for neurological diseases.
How similar studies have performed: Previous research has shown promise in developing imaging agents for neurological conditions, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Van Dam, Robert Michael — University of California Los Angeles
- Study coordinator: Van Dam, Robert Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.